Authors

• Jiaqi Tan (ORCID: https://orcid.org/0000-0001-5577-0641)
• Huihong Chen (ORCID: https://orcid.org/0009-0009-5295-4918)
• Xin Zhang (ORCID: https://orcid.org/0000-0003-1017-5210)
• Zhaoyu Pan
• Xiaohong Wu (ORCID: https://orcid.org/0000-0002-8259-3027)
• Zeyao Wang
• Tong Liu (ORCID: https://orcid.org/0000-0002-1389-7051)
• Xueying Wang (ORCID: https://orcid.org/0000-0001-6445-8887)
• Zihan Liu (ORCID: https://orcid.org/0009-0007-8455-843X)
• Juncheng Wang (ORCID: https://orcid.org/0000-0003-1696-1052)
• Yewen Zhu
• Jiaoyan Cao
• Zhongjie Shi (ORCID: https://orcid.org/0000-0003-2257-5158)
• Yuxi Tian
• Zhenjiang Li

Institutions

• Central South University (CN)
• Harbin Medical University (CN)
• Wayne State University (US)
• Third Affiliated Hospital of Harbin Medical University (CN)
• Fourth Affiliated Hospital of Harbin Medical University (CN)
• Xiangya Hospital Central South University (CN)

Publication Details

Journal

Molecular Cancer

Published

2025-06-07

DOI

https://doi.org/10.1186/s12943-025-02360-4

Citations

6

Primary Topic

Cancer Immunotherapy and Biomarkers

Type

article

Field-Weighted Citation Impact

6.27

Funders

• Harbin Medical University
• National Natural Science Foundation of China
• China Postdoctoral Science Foundation
• Natural Science Foundation of Hunan Province
• Natural Science Foundation of Heilongjiang Province
• Heilongjiang Provincial Science and Technology Department
• National Outstanding Youth Science Fund Project of National Natural Science Foundation of China